On-the-road driving performance the morning after bedtime use of suvorexant 15 and 30 mg in healthy elderly

RATIONALE: Suvorexant is a first-in-class orexin receptor antagonist for treating insomnia. There is a general concern that hypnotics may impair next-morning driving ability. OBJECTIVE: The objective of this study was to evaluate next-morning driving performance in older adults after single and repe...

Descripción completa

Detalles Bibliográficos
Autores principales: Vermeeren, Annemiek, Vets, Eva, Vuurman, Eric F.P.M., Van Oers, Anita C.M., Jongen, Stefan, Laethem, Tine, Heirman, Ingeborg, Bautmans, An, Palcza, John, Li, Xiadong, Troyer, Matthew D., Wrishko, Rebecca, McCrea, Jacqueline, Sun, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2016
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4989000/
https://www.ncbi.nlm.nih.gov/pubmed/27424295
http://dx.doi.org/10.1007/s00213-016-4375-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4989000/
https://www.ncbi.nlm.nih.gov/pubmed/27424295
http://dx.doi.org/10.1007/s00213-016-4375-x

Ejemplares similares